Journal Articles
Our work in Journal Articles
-
Lifetime Exposure to Smoking, Epigenetic Aging, and Morbidity and Mortality in Older Adults
Scheffer Center experts examine how three epigenetic aging measures are associated with parental smoking, smoking in youth, and smoking in adulthood, and whether these epigenetic aging measures mediate the link between smoke exposure and morbidity and mortality.
Categorized in -
Rating the Comparative Efficacy of State-Level Cannabis Policies on Recreational Cannabis Markets in the United States
Schaeffer experts identified identified key cannabis policies and their provisions enacted by U.S. states; rated their theoretical efficacy in a restrictive form for reducing problematic use and impaired driving in the context of a recreational cannabis market as judged by experts; and rated the strength of evidence for each policy.
Categorized in -
Comparison of Medical Cannabis Use Reported on a Confidential Survey vs Documented in the Electronic Health Record Among Primary Care Patients
Schaeffer experts estimate the primary care prevalence of medical cannabis use according to confidential patient survey and to compare the prevalence of medical cannabis use documented in the EHR with patient report.
Categorized in -
Trends in the Use of Cannabis Products in Canada and the USA, 2018 – 2020: Findings From the International Cannabis Policy Study
There is little information on consumption patterns across the diverse range of cannabis product types. This paper examines trends in consumption patterns in Canada and the United States (US) between 2018-2020.
Categorized in -
The Eldercare Facility Ordinance of Los Angeles: A Synthetic Control Analysis of Residential Care Development and Growth
Using California State Department of Social Services residential care and census place data, this study compares the pre and post effect of the ordinance on the number of large residential care facilities developed in Los Angeles with a comparison group using synthetic control analysis.
Categorized in -
Addressing Challenges to Alternative Payment Models for New Alzheimer’s Disease Therapies for US Commercial Payers
Developing a blueprint to overcome challenges in implementing new payment models will ensure better access.
Categorized in -
Use of Prescription Medications with Cardiovascular Adverse Effects Among Older Adults in the United States
Schaeffer experts examined the association between the concurrent use of prescription medications with known risk of a major adverse cardiovascular event (MACE) (“MACE medications”) and the risk of such events among older adults.
Categorized in -
Opioid and Naloxone Prescribing Following Insertion of Prompts in the Electronic Health Record to Encourage Compliance With California State Opioid Law
A new study by experts at the USC Schaeffer Center for Health Policy and Economics and Kaiser Permanente finds Naloxone prescriptions increased while opioid prescriptions decreased.
Categorized in -
Messages in Prescription Drug Advertising for Four Chronic Diseases, 2003-2016: A Content Analysis
Examining the frequency and content of messages related to pharmacological and evidence-based, non-pharmaceutical treatments in direct-to-consumer advertising (DTCA) for prescription drugs treating four chronic diseases in the United States.
Categorized in -
Value of Triage Treatment Strategies to Distribute Hepatitis C Direct-Acting Antiviral Agents in an Integrated Healthcare System: A Cost-Effectiveness Analysis
This study aimed to assess the cost-effectiveness of fibrosis-based direct-acting antiviral treatment policies for patients with chronic hepatitis C virus at the Kaiser Permanente Mid-Atlantic States health system.
Categorized in